RESEARCH ARTICLE Open Access

Micafungin for the treatment of proven and suspected invasive candidiasis in children and ulticenter prospective of favorable response were observed. Survival at EOMT was 90 % (97/108 patients), with rates of 97 % (35/36) and 86% Viscoli et al. BMC Infectious Diseases (2014) 14:725 DOI 10.1186/s12879-014-0725-7University of Genoa, L.go R. Benzi, 10-16132 Genoa, Italy Full list of author information is available at the end of the article(62/72) among children and adults, respectively. Conclusions: Micafungin was well tolerated in a heterogeneous real world population with a bimodal age distribution. A high rate of favorable response to micafungin treatment was reported in both proven and suspected IC